6 Amendments of Nikos CHRYSOGELOS related to 2013/0304(COD)
Amendment 7 #
Proposal for a directive
Recital 4
Recital 4
(4) New psychoactive substances, which imitate the effects of substances scheduled under the UN Conventions, are emerging frequently and are spreading fast in the Union. Certain new psychoactive substances pose severe health, social and safety risks, as ascertained by [Regulation (EU) No …/… on new psychoactive substances]. Under that Regulation, measures may be taken to prohibit the production, manufacture, making available on the market including importation to the Union, transport, and exportation from the Union of new psychoactive substances posing severe health, social and safety risks. To effectively reduce the availability of new psychoactive substances that pose severe risks to individuals and society, and to deter trafficking in those substances across the Union, as well as the involvement of criminal organisations, permanent market restriction measures adopted under that Regulation should be underpinned by proportional criminal law provisions, aimed solely to producers, suppliers and distributors rather than individual consumers.
Amendment 8 #
Proposal for a directive
Recital 4 a (new)
Recital 4 a (new)
(4a) To effectively reduce the demand of new psychoactive substances that pose severe health, social and safety risks, dissemination of evidence-based, public health information and early warnings to consumers should be an integral part of an inclusive and participatory strategy to prevent and reduce harm.
Amendment 9 #
Proposal for a directive
Recital 4 b (new)
Recital 4 b (new)
(4b) An objective impact assessment based upon scientific evidence is required to evaluate the utility of different control and regulatory options, for example through consumer safety or medicines legislation. A review of the New Zealand model should be undertaken to assess costs and benefits for its incorporation in the EU system. Countries wishing to trial new regulatory approaches should be supported to rigorously evaluate the impact of their legislation on public health outcomes.
Amendment 11 #
Proposal for a directive
Recital 5
Recital 5
(5) The new psychoactive substances subjected to permanent market restriction pursuant to [Regulation (EU) No …/… on new psychoactive substances] should, therefore, be covered by the Union criminal law provisions on illicit drug trafficking, supported by effective identification, early warning, prevention, treatment, and information dissemination measures. This would also help streamline and clarify the Union legal framework, as the same criminal law provisions would apply to substances covered by the UN Conventions and to the most harmful new psychoactive substances. The definition of ‘drug’ in the Framework Decision 2004/757/JHA should, therefore, be amended.
Amendment 18 #
Proposal for a directive
Article 1 – paragraph 1 – point 2 – introductory part
Article 1 – paragraph 1 – point 2 – introductory part
Council Framework Decision 2004/757/JHA
Article 9
Article 9
(2) In Article 9, the following paragraphs 3, 4 and 45 are added:
Amendment 19 #
Proposal for a directive
Article 1 – paragraph 1 – point 2
Article 1 – paragraph 1 – point 2
Council Framework Decision 2004/757/JHA
Article 9 – paragraph 5 (new)
Article 9 – paragraph 5 (new)
5. By [5 years after entry into force of this Directive and every 5 years thereafter], the Commission shall assess the costs and benefits of regulatory models used in third countries and if more beneficial than current EU models, to make an appropriate legislative proposal to amend this framework decision accordingly.